6 million cancer victims were not told about....

[Guest guest]

June 1, 2002

From June 1, 1990 until June 1, 2002, six million Americans died from cancer.

They were not told about PSK/Krestin & PSP, extracts from the Coriolus

versicolor mushroom.

In 1989, the U.S. National Cancer Institute (NCI) highly praised and virtually

endorsed

these extracts as anti-cancer agents. The U.S. Food and Drug Administration

(FDA)

has banned their importation from Japan.

Rose Ann Antich, State Senator, Merrillville, Indiana 46410

Greg , M.D., Director, Indiana State Health Department, 2 N. Meridian St.,

Indianapolis, IN 46204

I have posted this letter to the Internet in the hope that it might benefit

someone, somewhere.

Senator Antich and Dr. , the fate of cancer victims throughout the United

States

might depend upon what course of action you decide to take!

Dear Senator Antich and Dr. ,

After reading this letter, I hope you will direct some questions to the

Directors of the

U.S. Food and Drug Administration (FDA) and the U.S. National Cancer Institute

(NCI).

The Director of the FDA should be asked:

" Why aren't Americans being told about the anti-cancer mushroom

extracts PSK/Krestin & PSP,

and why can't these extracts be imported from Japan? "

Senator Antich and Dr. , let me afford you a little bit of my

research history relative

to PSK/Krestin and PSP.

On January 25, 2001, I became aware of these passages in ADVANCES IN

APPLIED MICROBIOLOGY,

'Antitumor and Antiviral Substances from Fungi', VOLUME 34, Academic Press,

Inc., 1989,

pages 183 to 262 (All bold face emphasis in this letter is mine.):

Page 183: " The United States National Cancer Institute (NCI) has recently

intensified its emphasis

upon natural products as a source of new drug discovery. The initial impetus for

these efforts stemmed

both from the abundant precedents for the discovery of a wide variety of

valuable medicinal agents

across essentially all pharmaceutical classes and from a comprehensive

restructuring and

expansion of scope of the NCI drug-screening programs.... "

Page 236: " Antitumor polysaccharides have been obtained from a number of

Basidiomycetes

including Coriolus consors, Coriolus versicolor.... "

Page 237: " ....The polysaccharide-protein complex has been found to be effective

in the treatment

of solid types of Ehrlich carcinoma or sarcoma 180 cancerous tumors in mice. The

effective substance

exhibits neither cytotoxicity nor side effects commonly seen in connection with

the use of

conventional anticancer agents, such as decrease in the number of leucocytes,

anemia of the liver

and other organs, atrophy of the spleen, loss of body weight, and loss of

appetite. "

Page 238: " The polysaccharide PS-K (j.s.r. - PSK) has been extracted by Hirase

et al. (1970) from

Coriolus versicolor. It is found to be effective against sarcoma 180 when

administered orally.

PS-K is a B-(1,4)-glucan containing 10% protein. Its water solubility and

effectiveness with

oral administration seems to be due to its protein-containing structure (Hata,

1977).... "

Page 238: " ...Polysaccaropeptide (j.s.r. - PSP) produced by C. versicolor has a

wide range

of antitumor activities, inhibiting Ehrlich ascites tumors, leukemia P388, and

sarcoma 180,

and the growth of cells of gastric tumor, lymph, and monocytic leukemia (Yang et

al., 1987).... "

Page 238: " ....Both United States patents 4,271,151 and 4,289,688 issued to

Hotta et al. (1981a,

relate to protein-bound polysaccharides which have excellent antitumor activity

not only by

intraperitoneal administration but also by oral administration.... "

Page 238: " ....The polysaccharides (j.s.r. - PSK & PSP) have been contemplated

for use against

a wide variety of mammalian cancers, including mammary cancer, gastrointestinal

cancers,

such as those of the esophagus, stomach and large colon; lung cancer and brain

tumors.... "

On January 28, I found this information on the Internet, 'PSK, A Non-Toxic

Natural Cancer Treatment'

(Site no longer available -

http://www.wellweb.com/ALTERN/cancer/psk/contents.htm):

" PSK is an all-natural mushroom extract made from the mushroom Coriolus

versicolor. "

" PSK has been available in Japan for more that 15 years, where it has

government approval

to be used for a number of cancers. PSK is also covered by Japanese health

insurance. Based solely

on Japanese sales, PSK is the number-one selling anti-cancer agent in the

world. "

" There have been nearly four hundred scientific studies done on the safety

and effectiveness of PSK.

Some show increased survival rates and improved quality of life without toxic

side effect. "

" In the US, PSK is little known and not readily available. In Japan it is

one of the most used

therapeutic substances. There are a large number of studies about PSK that tend

to prove

certain benefits. PSK is a polysaccharide complex with the potential to enhance

and stimulate

the immune system. PSK is derived from a fungus, an edible mushroom called

Coriolus Versicolor.

In some Western cultures it is nicknamed 'Turkey Tail'. "

" A common problem with nutritional supplements is that many are not readily

'bioavailable', i.e. in a

form that the body can absorb them. PSK can be taken orally and and is readily

absorbed. Relative to

most alternative therapies, research and studies of PSK as an anti-cancer agent

are abundant

and largely positive, and show a moderate response primarily when used as

adjuvant therapy

in combination with certain conventional treatments. Since PSK is virtually free

of side effects, aside from

the cost, there may be little if any downside to using it in situations

supported by well designed studies --

again in conjunction with, not instead of conventional therapies

for which there is evidence of efficacy. " (Author's emphasis)

In the article, Sheim, Ph.D., a retired researcher from the National

Cancer Institute, stated:

" It is noteworthy that a non-toxic Japanese drug, PSK, containing complex

polysaccharide ingredients

derived from a fungus, has demonstrated significant anticancer activity

comparable to those

of standard anticancer drugs in several large randomized clinical trials. PSK is

administered orally

in these studies at a typical dosage of 3 grams daily. For example, PSK plus

radiation yielded 22%

5-year survival for stage III non-small cell lung cancer v. 5% 5-year survival

for those patients

receiving radiation alone, a statistically significant difference. "

" In addition, PSK as an oral adjuvant treatment following curative surgery for

colon cancer was found

to yield 30% 8-year disease free survival v. 10% for patients taking placebo, a

statistically significant

difference, in a randomized, double-blind clinical trial. PSK was found to

sharply increase the

motility and phagocytic activity of polymorphonuclear leukocytes, which the

investigators found

significant based upon other findings that prognosis of cancer patients was

positively correlated with the

degree of cellular infiltration around tumor sites. PSK was also found to yield

significant activity and

prolongation of survival when administered to nude mice implanted with human

ovarian cell line

xenografts. "

Now, I found all of this information very interesting, but it did not overwhelm

me.

Several months later, on August 4, I was overwhelmed when I read this passage in

THE CANCER INDUSTRY, by Ralph Moss, Ph.D., page 91:

" In fact, the best-selling cancer drug worldwide is Krestin (j.s.r. - PSK), an

immunostimulant

produced by Kureha and marketed by Sankyo, both Japanese companies. With 1987

sales of

$359.1 million, Krestin is in fact the nineteenth top-selling drug in the world

(Health Week, 3/3/87).

Yet the drug is not available in the United States. Company officials indicated

that Krestin was not being

marketed in the United States in part because of difficulty of obtaining FDA

approval. "

On August 20, I found this information on the Internet, 'the Magic of Medicinal

Mushrooms'

(Site no longer available,

http://www.alternativemedicine.com/digest/issue36/36046.shtml_old):

" Coriolus....More recently clinical trials have proven it effective for cancer

patients because of

its anti-tumor action and ability to stimulate the immune system.... "

" Coriolus is the top-selling nutritional product in Japan today and the number

one selling medicinal

mushroom product in the world for cancer treatment (over $600 million annually

in Japan,

Europe and North America). This is the only mushroom to have gone through

double-blind

clinical trials in humans. Tested both singly and in combination with

conventional therapies, it doubled

or tripled survival rates and immune function. In Japan, the extract known as

PSK or Krestin,

is the top cancer medicine. It even combats the disabling side effects of

surgery, chemotherapy,

radiation and compromised cellular immunity attributed to conventional cancer

drugs.

Studies following patients' post colon cancer surgery showed that survival rates

doubled when patients

were given Coriolus extract; survival rates also improved for patients with

non-small cell lung cancer

who were treated with radiation. Other clinical studies showed that Coriolus

enhanced cytotoxicity

(cancer-killing ability) by 500% within seven days, especially for sarcoma,

increasing the numbers

and effectiveness of immune cells while also augmenting resistence to bacterial

infection. "

In August, I began to, and have continued to, alert Officials in the Washington,

D.C., area to these findings.

Here is more data that I discovered after August; access the National Library of

Medicine

(MEDLINE, www.ncbi.nlm.nih.gov/pubmed) and type in the word combination psk psp;

here are

the salient passage from 4 of the 6 abstracts that will appear:

1. Ooi VE, Liu F. " ....Three antitumor mushroom polysaccharides, i.e.

lentinan, schizophyllan and

protein-bound polysaccharide (PSK, Krestin), isolated respectively, from

Lentinus edodes,

Schizophyllum commune and Coriolus versicolor, have become large market items in

Japan.

Lentinan and schizophyllan are pure beta-glucans, whereas PSK is a protein-bound

beta-glucan.

A polysaccharide peptide (PSP), isolated from a strain of Coriolus versicolor in

China, has also

been widely used as an anti-cancer and immunomodulatory agent. Although the

mechanism

of their antitumor action is still not completely clear, these polysaccharides

and polysaccharide-protein

complexes are suggested to enhance cell-mediated immune responses in vivo and in

vitro and act as

biological response modifiers.... "

2. Kidd PM. " ....Two proteoglycans from Coriolus versicolor - PSK

(Polysaccharide K) and PSP

(Polysaccharide-Peptide) - have demonstrated the most promise. In Japanese

trials since 1970,

PSK significantly extended survival at five years and beyond in cancers of the

stomach,

colon-rectum, esophagus, nasopharynx, and lung (non-small cell types), and in a

HLA B40-positive breast cancer subset. PSP significantly extended five-year

survival in

esophageal cancer. PSP significantly improved quality of life, provided

substantial pain relief,

and enhanced immune status in 70-97 percent of patients with cancers of the

stomach,

esophagus, lung, ovary, and cervix. PSK and PSP boosted immune cell production,

ameliorated chemotherapy symptoms, and enhanced tumor infiltration by dendritic

and cytotoxic T-cells.

Their extremely high tolerability, proven benefits to survival and quality of

life,

and compatibility with chemotherapy and radiation therapy makes them well suited

for cancer management regimens. "

3. Ng TB. " ....PSP administered to patients with esophageal cancer, gastric

cancer and lung cancer,

and who are undergoing radiotherapy or chemotherapy, helps alleviate symptoms

and prevents the decline in immune status. "

6. Yang MM, Chen Z, Kwok JS. Contains this passage relative to PSP - " ....and

was named

small peptide of Coriolus versicolor, SPCV. It was found that SPCV possesses

potent cytotoxic effect

on human tumor cell lines of HL-60, LS 174-T, SMMU-7721, and SCG-7901.... "

IN MEDLINE, THERE IS NO CITATION UNDER A 'CANCER' SUBJECT HEADING FOR THE

1989 RESEARCH (SEE ABOVE - 'ANTITUMOR AND ANTIVIRAL SUBSTANCES FROM FUNGI')

PUBLISHED BY THE U.S. NATIONAL CANCER INSTITUTE (NCI).

DID SOMEONE AT THE NCI WANT TO CONCEAL THESE FINDINGS?

ARE CERTAIN FACTIONS WITHIN THE NCI CORRUPT?

More research can be found in MEDLINE and the Internet relative to the benefit

of using

PSK and PSP as adjuvant therapy in the treatment of cancer. Let me quote one

more source;

it was written by 8 Japanese Doctors who, in 1997, were associated with the

Department

of Radiology and Radiation Oncology, Gunma University School of Medicine,

Maebashi, Gunma,

Japan and can be found at http://www.cancerprev.org/Journal/Issues/21/1/172:

ABSTRACT: To evaluate the efficacy of Krestin (PSK) as adjuvant treatment after

radical

radiation therapy (RT) for non-small cell lung cancer (NSCLC), treatment results

of 225 patients

with NSCLC treated with RT followed by adjuvant administration of PSK between

1976 and 1989

were analyzed. Of these patients, 170 (76%) had squamous cell carcinoma. In the

patients with

squamous cell carcinoma of the lung, PSK was given only when the tumor showed

satisfactory

shrinkage (complete or partial response) after completion of RT. The treatment

outcomes were compared

with those of the responders to RT not receiving PSK. The 5-year survival rates

of patients with stages I-II

and stage III disease were 39 and 26%, respectively, while the non-administered

responder group's

were 17 and 8%. These differences are statistically significant. An improvement

in the treatment

results with combined use of appropriate immuno-modulating drugs is anticipated

in the future.

When clinical trials of the efficacy of thse drugs are conducted, the agents

should be given to the patients

with satisfactory tumor regression after RT, although they still take much time

and cost. "

Since August, 2001, I have mailed numerous letters to Representative J.

Visclosky and

the U.S. National Institutes of Health (NIH) and U.S. National Cancer Institute

(NCI) about this important

health matter.

This was Representative Visclosky's response as it appeared in the March 11,

2002 edition

of 'The TIMES' (Northwest Indiana):

" A spokesman for Visclosky said this sort of thing is something that gets

passed along to

proper authorities, like the National Institute of Health. "

No one from the NIH or NCI has ever responded to me about this matter.

As the matter now stands, I definitely think there are certain factions within

the

NIH and NCI that are corrupt!

On September 7, 2001, I wrote a letter to Representative Visclosky that contains

this headline -

Congressman Visclosky, on my behalf, would you please make sure that the

FDA responds to my letter.

The letter contained the anti-cancer information about PSK and PSP that I have

highlighted

in this letter.

I have continued to mail letters about this health issue to Representative

Visclosky and the FDA

and others (see below - 'Copies to - ').

No response yet from Representative Visclosky or the FDA.

Are certain factions within the FDA also corrupt?

Senator Antich and Dr. , let me repeat - The fate of cancer victims

throughout

the United States might depend upon what course of action you decide to take!

Let's imagine this scenario - The PSK & PSP report was published by the NCI in

1989.

Let's assume it would have taken 5 months to alert all the medical community of

the

U.S.A. to the potential usefulness of these mushroom extracts as adjuvant

therapy

in the treatment of various forms of cancer.

Correct me if I am wrong, but the figure I most often see for the yearly cancer

deaths in the U.S.A.

is 500,000.

Then, from June 1, 1990, to June 1, 2002, 6 million (500,000 x 12) cancer

victims could have

been told about the potential benefit of using PSK & PSP as adjuvant therapy in

their treatment.

The sad fact is - 6 million cancer victims living in the United States of

America

were not told!

Senator Antich and Dr. , I hope you ask the Director of the National

Cancer Institute this question -

Why aren't Americans being told about the anti-cancer potential of Lentinan,

an extract from the Shiitake mushroom?

I assume that the American Type Culture Collection has a close working

relationship with

the National Cancer Institute. This information about Lentinan was published in

1993 by researchers,

Shung-Chang Jong and J.M. Birmingham, associated with the American Type Culture

Collection;

refer to ADVANCES IS APPLIED MICROBIOLOGY, VOLUME 39, Academic Press, pages 153

to 184,

'Medicinal and Therapeutic Value of the Shiitake Mushroom':

Page 154: " ....Reputed antitumor components vary in chemical nature, but the

most important may prove

to be a polysaccharide that acts as a host defense potentiator (Jong et al.,

1991).

Page 157: " Lentinan is a B-glucan (Hamuro et al., 1976).... "

Page 157: " The anti-tumor fraction of lentinan is of high molecular weight (T.

Sasaki et al., 1976).... "

Page 158: " Lentinan appears to be a potent host defense potentiator which

improves homeostasis

of the host against cancer or infection (Chihara et al., 1989). "

Page 159: " Maeda and Chihara (1973a) found that lentinan activated the

anti-tumor effect

of peritoneal-exudate in rats against sarcoma 180 in vivo.... "

Page 163: " Miyakoshi and co-workers (1984) indicate that lentinan can inhibit

cancer in humans.... "

Page 164: " a. Combination with Other Therapeutic Agents. Badger (1984) showed

that lentinan

in combination with chemotherapy increased survival 50% when compared

to chemotherapy alone.... "

Pages 176-177: " Lentinan first extracted from the fruiting body of L. edodes is

a pure B-1, 3-glucan

containing only glucose. It appears to act as a host-defense potentiator which

can improve

the physiological constitution of the host against cancer, as well as various

kinds of infections,

and restore or augment the ability of responsiveness of the host to bioactive

substances, such as

lymphokines or cytokines.... "

Page 177: " ....Remarkable life span prolongation has been achieved in patients

with advanced and recurrent stomach, colorectal and breast cancer. Lentinan is

commercially available for clinical use. In 1987 it was the eighth top-selling

anti-cancer drug in Japan

with 2.2% share of the market valued at $3 million (Fukushima, 1989). "

Page 177: " The use of cultivated edible mushrooms, such as L.edodes, as a source

of biologically

active principles offers obvious advantages. Edibility increases the likelihood

of a safe,

tolerated principle, while cultivability assures an adequate supply. However,

cultivation

of the mushroom need not be a limitation when active principles can be derived

from its mycelial cultures,

as in the case with LEM. "

Page 177: The biologically active components isolated and identified in edible

fungi show great promise

and should be further exploited for their therapeutic effects, either as dietary

components

or as purified drugs. The cure for the diseases that plague mankind,

particularly cancer and

AIDS, may lie with the biochemistry of edible mushrooms.

Senator Antich and Dr. , I hope you ask the Director of the National

Cancer Institute this question -

What is the U.S. National Cancer Institute's (NCI) current evaluation

of TAC (Thiazolidine-4-carboxylic acid), an anti-cancer extract from the

Shiitake mushroom?

Representative J. Visclosky and Ms. Dorothy A. Foellmer of the NCI did not

have the courtesy

to afford me a copy of the letters in which these passages appear. If it had not

been for the fact

that a Schererville, Indiana citizen mailed to me a copy of the letters, I would

have never

known of their existence!

This passage appears in a May 16, 2001 letter sent by Rep. Visclosky to the

Schererville citizen:

" Several years ago my office contacted the Department of Health and Human

Services (HHS) to inquire

about S. ' cancer cure proposal (j.s.r. - It contains TAC). The

response we received from the

National Cancer Institute indicated that Mr. ' cure would have negative

effects on patients,

and was not a safe cure for any cancer. To ensure that there has not been any

change in the status

of Mr. ' proposal, I have taken the liberty of forwarding your

correspondence to me to

Tommy , the Secretary of the Department of Health and Human Services.

Enclosed please find a copy of my letter to Secretary , asking that he

address your concerns. "

On behalf of Secretary , Ms. Foellmer (Director, Office of Legislation

and Congressional

Activities - NCI) wrote a June 28, 2001 letter to that same Schererville

citizen; this passage appears:

" In your letter to Mr. Visclosky, you expressed an interest in the work of Mr.

S. . Mr.

has made claims on the internet that a compound, Thiazolidine-4-carboxylic acid

(TAC), can cure cancer.

Since 1955, the National Cancer Institute (NCI) has actively evaluated materials

that might be useful

in the discovery of new agents for cancer treatment through the Developmental

Therapeutics Program (DTP).

Extensive testing of TAC was conducted in 1979 by DTP. No anti-tumor activity

was found and

the testing was stopped. As part of the drug discovery process, DTP receives

agents from many sources,

including universities, research institutes, government agencies, biotechnology

companies, and

pharmaceutical houses. The testing done on TAC was initiated because of reports

from a human trial

that was done in Spain. The compound was tested on numerous animal tumor models,

but failed to show any anti-tumor activity. "

Apparently, Ms. Foellmer was unaware of the cancer research of two of the

world's foremost

doctors - Dr. V. Schally, a 1977 Nobel Prize winner in Medicine,

and Dr. Gosalvez, who was for 30 years the Director of Biochemcial

Research for

the Kingdom of Spain.

TAC is an integral component in the cancer research of Dr. Schally and Dr.

Gosalvez.

From 1994 to 2000, Dr. Schally published 13 reports in which he said that

compounds containing TAC

might be effective in causing the " inhibition of growth " of these Cancers -

Pancreatic, Prostate,

Renal (Kidney), Breast, Small Cell Lung Carcinoma (SCLC), Glioblastoma (Brain

tumor)

and Ovary.

Dr. Schally's final refinement containing TAC, compound RC-3940-II, was patented

by

Tulane University, New Orleans, Louisiana.

These passages are found in a July 20, 2001 letter to S. from Dr.

Gosalvez:

" In 1981, we found unfortunately that Thiazolidine Carboxylic Acid - alone - can

not cure cancer

because it only reverses to normality the benign and less malign cancer cells.

The malignant cancer cells

are not reversible to normality by Thioproline. In 1989 we finished the

development of the technique

of 'Cancer Reversal by Dual Strategy', the combination of Thiazolidine

Carboxylic Acid

with Quelamycin, our transient ferric complex of the cytotoxic agent Adriamycin.

Quelamycin kills

specifically the malignant cancer cells that are not reverted to normality by

Thioproline (j.s.r. - TAC). "

" Due to the general lack of interest in our technique for Reversal of Cancer by

Dual Strategey we reached,

in 1989, - through very important indirect ways - (j.s.r. - King and

Queen Sofia of Spain

and former President Bush and First Lady Barbara Bush) - the top military

authorities

of the United States of America with the request of a pilot clinical trial by

the Military Hospitals

of United States of the combination of Thioproline and Quelamycin in terminal

cancer patients.

I am firmly convinced that this trial was conducted successfully and that then

the American military

implemented a massive study of the technique of Cancer Reversal by Dual Strategy

that

endured the last ten years. I think that their results will be soon communicated

to the American people

and to the World by the top American leader.... "

Thus the question remains - Is TAC an effective anti-cancer agent? Dr. Schally

and Dr. Gosalvez

think it is; however, Ms. Foellmer thinks it is not.

Senator Antich and Dr. , here again are the three primary questions

that I hope you ask of Federal Officials -

1. Director of the U.S. Food and Drug Administration (FDA): Why aren't Americans

being told

about the anti-cancer mushroom extracts PSK/Krestin & PSP,

and why can't these extracts be imported from Japan?

2. Director of the U.S. National Cancer Institute (NCI): Why aren't Americans

being told

about the anti-cancer potential of Lentinan, an extract from the Shiitake

mushroom?

3. Director of the NCI: What is the NCI's current evaluation of TAC

(Thiazolidine-4-carboxylic acid),

an anti-cancer extract from the Shiitake mushroom?

(MEDLINE, 6599915, states that TAC contains " anti-cancer molecules " .)

Senator Antich and Dr. , thank you for giving this matter your time and

attention.

The fate of Cancer victims throughout the world might depend upon you.

Sincerely, S. , 5086 Sunrise Ave., Portage, Indiana 46368, (219)

763-1933

Post Script -

A. America's Top Doctors should be asked 13 Questions about Cancer, AIDS,

Anthrax, Leukemia and Alcoholism.

Join the 'TIM Lobby' (Truth in Medicine).

Simply call your Member of Congress (Rep. Visclosky, 219-884-1177)

and say you want answers to the 13 health questions asked by S. .

1. Cancer/TAC - In a 1979 Spanish clinical trial, the chemical TAC caused the

" ....disappearance of evidence of cancer. " Why can't this trial be repeated with

'mega-doses'

of TAC & vitamin C and the mushroom extracts PSK/Krestin, PSP & Lentinan?

2. Cancer/TAC - Dr. Schally (Nobel Prize in Medicine) invented and Tulane

University patented

RC-3940-II which contains TAC. RC-3940-II is expected to cause the " inhibition

of growth "

of pancreatic, prostate, kidney, breast, lung, brain and ovary cancer. When will

Tulane sell RC-3940-II?

3. Cancer/TAC - When will Americans be told about TAC & Quelamycin which have

been administered

to cancer patients in U.S. Military Hospitals since 1990?

4. Cancer/TAC - What is the National Cancer Institute's (NCI) current evaluation

of TAC?

5. Cancer/PSK & PSP - Why are Americans denied the No.1 cancer medicine

PSK/Krestin & PSP?

Worldwide sales top $600 million, and the NCI highly praises it.

6. Cancer/Lentinan - Why aren't Americans being told about Lentinan?

Japanese research indicates that it is anti-cancerous.

7. AIDS/L-MTCA - Why aren't AIDS patients being provided with L-MTCA?

It contains a chemical that can " inactivate " HIV.

8. Anthrax/L-MTCA - Could L-MTCA be used against anthrax?

9. Leukemia - Would the combination of d-penicillamine & copper and vitamin C

be a good treatment for Leukemia?

10. Alcoholism - Shouldn't all drinkers be told about zinc and vitamins B-6 & C?

11. Cancer/TAC - In 1996, the NCI published an article about the decrease of the

cancer death rate

in the U.S.A. Did it take into account the Military treatment? (TAC &

Quelamycin)?

12. Cancer/Dr. Rabson - Did Dr. Rabson respond to the 2/13/2000 letter of

Dr. Gosalvez (former Director of Spanish biochemical research)?

13. Cancer/PSK & PSP - Why is there no citation in MEDLINE under a 'CANCER'

subject heading

for significant research reported in 1989 by the NCI about the anti-cancer power

of PSK/Krestin & PSP?

B. My latest bulletin reads -

Cancer, AIDS & Alcoholism

World's No.1 cancer medicine is

sold NOW in America!

U.S. National Cancer Institute (NCI) says it shows a

" wide and excellent range of antitumor activity " .

It is natural, safe & inexpensive,

and is available in Eugene, Oregon.

Call toll-free: 1-888-330-4691.

My research is about Cancer,

AIDS, Alcoholism, Leukemia,

Anthrax, Lou Gehrig's Disease (ALS)

& Macular degeneration.

S. , U.S. Army Veteran (1955-57), N.W. Indiana Cable

T.V. Program, 9:30 PM. Mondays & 5:30 PM. Wed., (219) 763-1933,

5086 Sunrise Ave., Portage, IN 46368. Retired Librarian, Lake Ridge

Schools, Indiana, 31 yrs. The Cure for Cancer? , jsr1936@...

http://www.datadepo.com/cures for cancer/tac-cure.htm .

Health officials should answer 13 questions. Answers

could save lives! Investigation needed! Call your

Congressman! Indiana - Rep. J. Visclosky, (219) 884-1177

End of Bulletin

Copies to - President W. Bush, Former President Bush,

King and Queen Sofia of Spain, Rep. Visclosky, Rep. Kucinich, Dr.

Gosalvez, Dr. Schally,

President Cowen of Tulane, Secretary , Surgeon General, Mr. Dobbs (FDA),

Dr. Kirschstein (NIH), Dr. von Eschenbach (NCI), Dr. Klausner (NCI), Dr. Rabson,

(NCI),

Ms. Foellmer (NCI), Dr. Fauci (NIAID), Director (CDC), General , Dr.

Varmus, Dr. Vogelzang,

Dr. Prendergast, American Medical Association (A.M.A.), American Cancer Society

(ACS),

Lake/Porter County Medical Society, Cancercure Foundation, Gilda's Club, Mr.

Davich and others.